EASL (欧州肝臓学会) Best of ILC 2021に選出
2021-09-04
2021/6/23-6/24に開催されたEASL International Liver Congress 2021（欧州肝臓学会国際肝臓会議2021）にて、中島淳教授、今城健人医師の演題がBest of ILC 2021に選出されました。
Best of ILCスライドは、EASL CAMPUS（https://easlcampus.eu/ ）にて無料のメンバー登録することで閲覧可能となっております。
OS-681
Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator (SPPARM alpha), improves liver stiffness by MRE and serum liver and lipid parameters in NAFLD: a randomized, double-blind, placebo-controlled phase 2 trial
Atsushi Nakajima 1, Yuichiro Eguchi2, Kento Imajo1, Nobuharu Tamaki3 4, Hideki Suganami5, Toshiaki Nojima5, Ryohei Tanigawa6, Yuki Iida6, Rohit Loomba4
1Yokohama City University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Yokohama, Japan, 2Loco Medical General Institute, Kanada Mikatsuki Ogi, Japan, 3Musashino Red Cross Hospital, Department of Gastroenterology and Hepatology, Tokyo, Japan, 4University of California San Diego, NAFLD Research Center, La Jolla, United States, 5Kowa Company Ltd., Clinical Data Science Department, Tokyo, Japan, 6Kowa Company Ltd., Clinical Development Department, Tokyo, Japan